Health risk assessment of electromagnetic fields

2 views
Skip to first unread message

news....@googlemail.com

unread,
Mar 29, 2011, 11:45:52 AM3/29/11
to
In case you have not yet seen it, I hereby want to strongly recommend reading one of our recent papers, Dämvik M, Johansson O, “Health risk assessment of electromagnetic fields: A conflict between the precautionary principle and environmental medicine methodology”, Rev Environ Health 2010; 25: 325-333 (enclosed).

(Abstract)  The purpose of the precautionary principle is that legal requirements are to be made to safeguard against the possible health risks that have not yet been scientifically established. That a risk is not established cannot, therefore, be used as an excuse for not applying the principle. Yet, that rationale is exactly what is happening in the case of the possible health risks from exposure to electromagnetic fields (EMF). The scientists, representing both the World Health Organization and the European Commission, do not have at all the precautionary principle in mind when they report on health risks. Their starting point is instead to determine whether new research findings have been scientifically established and thus cannot be the basis for an amendment to the existing exposure limits. Uncertain indications of risk are ignored or played down. This approach is in conflict with European Union (EU) law, which requires that the degree of scientific uncertainty should be presented correctly. A thorough examination of the state of research shows many serious indications of possible health risks from exposure very far below existing limits for EMF. Case law, for other types of exposure, also shows that the precautionary principle can be applied on the basis of weaker evidence than that. Our investigation shows that the precautionary principle is not being used for its intended purpose in relation to exposure to EMF. The reason for this position is that decision-makers are being misled by inaccurate risk assessments.



Olle Johansson, assoc. prof.
The Experimental Dermatology Unit
Department of Neuroscience
Karolinska Institute
171 77 Stockholm
Sweden
&
Professor
The Royal Institute of Technology
100 44 Stockholm
Sweden)

Dämvik & Johansson 2010.pdf
Reply all
Reply to author
Forward
0 new messages